Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

27.15
Delayed Data
As of Dec 02
 +0.67 / +2.53%
Today’s Change
16.64
Today|||52-Week Range
42.49
-23.84%
Year-to-Date
3 Biotechs With Save-the-Date Catalysts on Tap
Nov 29 / MotleyFool.com - Paid Partner Content
Ready to Get In on Biotech? Check Out These 3 Stocks
Nov 20 / MotleyFool.com - Paid Partner Content
5 Biotech Stocks George Soros Is Buying
Nov 22 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close26.48
Today’s open26.63
Day’s range26.08 - 27.66
Volume1,508,255
Average volume (3 months)2,326,812
Market cap$3.3B
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-71.58%
Earnings growth (this year)-43.19%
Earnings growth (next 5 years)+16.76%
Revenue growth (last year)-49.17%
P/E ratioNM
Price/Sales58,810.80
Price/Book13.85

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC+0.47+2.42%
CBPOChina Biologic Produ...+1.21+1.07%
RAREUltragenyx Pharmaceu...-0.14-0.19%
ENDPEndo International P...-0.02-0.13%
Data as of 4:14pm ET, 12/02/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$61.0K
Annual profit (last year)-$164.4M
Net profit margin-269,578.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs